Montara Therapeutics Raises $28 Million for Safer Neurological Disease Treatments

Montara Therapeutics secures funding to develop safer and more effective treatments for neurological diseases.

AI-assisted, human-published

Latest headlines

Join us for funding and investment opportunities.

Stay connected!

If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here